{"title": "Open-source analytics tools for studying the COVID-19 coronavirus outbreak", "doi": "10.1101/2020.02.25.20027433", "citation_id": "2020.02.25.20027433v2", "date": "2020-03-05", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.25.20027433", "abstract": "<p>To provide convenient access to epidemiological data on the coronavirus outbreak, we developed an R package, nCov2019 (https://github.com/GuangchuangYu/nCov2019). Besides detailed real-time statistics, it offers access to three data sources with detailed daily statistics from December 1, 2019, for 43 countries and more than 500 Chinese cities. We also developed a web app (http://www.bcloud.org/e/) with interactive plots and simple time-series forecasts. These analytics tools could be useful in informing the public and studying how this and similar viruses spread in populous countries.</p>", "twitter_description": "To provide convenient access to epidemiological data on the coronavirus outbreak, we developed an R package, nCov2019 (https://github.com/GuangchuangYu/nCov2019). Besides detailed real-time statistics, it offers access to three data sources with detailed daily statistics from December 1, 2019, for 43 countries and more than 500 Chinese cities. We also developed a web app (http://www.bcloud.org/e/) with interactive plots and simple time-series forecasts. These analytics tools could be useful in informing the public and studying how this and similar viruses spread in populous countries.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNone.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nSource code and data are publically available on GitHub.\n\n<https://github.com/GuangchuangYu/nCov2019>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.25.20027433v2.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.25.20027433v2", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.25.20027433v2.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/05/2020.02.25.20027433.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.25.20027433v2", "access_rights": "restricted", "authors": ["Tianzhi Wu", "Xijin Ge", "Guangchuang Yu", "Erqiang Hu"]}